Clover Health Investments Corp. (CLOV) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Clover Health Investments... (CLOV)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

3.74

0.02 (0.54%)

At close: Jan 14, 2025, 3:59 PM

3.80

1.60%

Pre-market Jan 15, 2025, 05:27 AM EST

undefined% (undefined)

Bid	3.75
Market Cap	1.87B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.19
PE Ratio (ttm)	-19.68
Forward PE	n/a
Analyst	Buy

Ask	3.79
Volume	6,962,485
Avg. Volume (20D)	6,229,014
Open	3.78
Previous Close	3.72
Day's Range	3.60 - 3.86
52-Week Range	0.61 - 4.71
Beta	undefined

About CLOV

Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee....

[Show more]

Industry Medical - Healthcare Plans

Sector Healthcare

IPO Date Jun 12, 2020

Employees 552

Stock Exchange NASDAQ

Ticker Symbol CLOV

Website https://www.cloverhealth.com

Analyst Forecast

According to 2 analyst ratings, the average rating for CLOV stock is "Buy." The 12-month stock price forecast is $5, which is an increase of 33.69% from the latest price.

Buy 50.00%

Hold 50.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Clover Health Investments Corp. is scheduled to release its earnings on Mar 11, 2025, during market hours.
Analysts project revenue of $348.02M, reflecting a -31.79% YoY shrinking and earnings per share of -0.07, making a -53.33% decrease YoY.

Why Price Moved

2 months ago · Source

-15.63%

Clover Health Investments shares are trading lower... Unlock content with Pro Subscription

3 months ago · Source

+3.04%

Clover Health shares are trading higher after the Centers for Medicare and Medicaid Services increased the Star rating of its PPO Medicare Advantage plans to 4 Stars for 2025.

News

3 weeks ago · zacks.com

4 MedTech Stocks That Gained More Than 100% in 2024 With Room to Run

Here are some strong MedTech stocks - DOCS, CLOV, CLPT and HIMS - that are expected to provide promising gains.

3 weeks ago · seekingalpha.com

Recent Earnings Disappointment Could Be An Ideal Buying Opportunity For Clover Health

Clover Health's recent performance shows mixed results, with revenue growth but a significant share price drop, presenting a potential buying opportunity. Operational efficiency is improving, with bet...

1 month ago · seekingalpha.com

Clover Health: Balancing Innovation And Challenges

Clover Health Investments shows financial progress and challenges in 2024, with a focus on innovative Medicare Advantage plans and technology-driven healthcare solutions. The company achieved a 4.0 ra...

1 month ago · zacks.com

Here's Why Clover Health Investments (CLOV) Could be Great Choice for a Bottom Fisher

After losing some value lately, a hammer chart pattern has been formed for Clover Health Investments (CLOV), indicating that the stock has found support. This, combined with an upward trend in earning...

1 month ago · zacks.com

5 Medical Info System Stocks to Buy for a Stable Portfolio in 2025

Five medical info systems stocks have strong potential for 2025. These are: INSP, OMCL, TALK, BFLY, CLOV.

1 month ago · seekingalpha.com

Clover Health: Buy The Dip, Reap The Rewards

Clover's 32% dip following its Q3 earnings could be an opportunity to accumulate shares. Clover continues to grow its topline and improve its bottom line performance. Clover's latest star rating upgra...

2 months ago · zacks.com

Down -26.32% in 4 Weeks, Here's Why Clover Health Investments (CLOV) Looks Ripe for a Turnaround

Clover Health Investments (CLOV) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street anal...

2 months ago · zacks.com

Down -25.82% in 4 Weeks, Here's Why Clover Health Investments (CLOV) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for Clover Health Investments (CLOV) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall ...

2 months ago · zacks.com

Bears are Losing Control Over Clover Health Investments (CLOV), Here's Why It's a 'Buy' Now

2 months ago · zacks.com

CLOV Stock Declines Despite Q3 Earnings Beat, FY24 View Revised

Clover Health's third-quarter 2024 results continue to benefit from the strength of its business model.

2 months ago · zacks.com

Clover Health Investments, Corp. (CLOV) Reports Q3 Loss, Lags Revenue Estimates

Clover Health Investments, Corp. (CLOV) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.09 per share a year ago.

2 months ago · seekingalpha.com

Clover Health Investments, Corp. (CLOV) Q3 2024 Earnings Call Transcript

Clover Health Investments, Corp. (NASDAQ:CLOV ) Q3 2024 Earnings Conference Call November 6, 2024 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Andrew Toy - Chief Executive Officer...

2 months ago · seekingalpha.com

Clover Health's Rally: The Payoff Of A Profitable Pivot

Clover Health's pivot to profitability over growth following the divestiture of the non-insurance segment at the end of 2023 has led to significant earnings improvements. The newly launched Counterpar...

2 months ago · zacks.com

CLOV Q3 Estimates Unchanged Before Earnings: How to Play the Stock?

The continued strength in Clover Health's offerings is likely to have driven the company's performance in the third quarter.